Clinical Trial: Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase II Study of VCD/IE in the Treatment of the Patients With Ewing's Sarcoma Family of Tumors
Brief Summary: The purpose of this clinical trial was to evaluate the efficacy and tolerability of the sequential therapy of VCD/IE in the patients with ESFT.
Detailed Summary: 80-90% patients of ESFT will develope disease progression during the period of local treatment (surgery or radiation). The survival has been improved in these 30 years due to chemotherapy. VCD/IE is widely used in the world for the patients with ESFT, but it is rarely used in China due to its high dosage.
Sponsor: Fudan University
Current Primary Outcome: Response Rate [ Time Frame: every two cycles ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Toxicity [ Time Frame: every cycle ]
Original Secondary Outcome: Same as current
Information By: Fudan University
Dates:
Date Received: December 5, 2007
Date Started: March 2007
Date Completion: September 2009
Last Updated: July 6, 2009
Last Verified: July 2009